TheNewsRoom | Prof. Peter Sleight Dept of Cardiovascular Medicine Oxford, UK, comments on the outcome of the TRANSCEND trial

All of these words:

The exact phrase:

None of these words:

Types

	All		Image
	Video		Text

Categories

Date

Providers

Advanced Search

Learn More

Voxant's Newsroom has a huge collection of video, text, and photos from over 300 news sources. Find in-depth news, embed it to your site, and build community!

About Us
Embedding
Getting Paid
NewsPERKS

Connect

Blog
Forum
Help/Support
The Gallery

Bookmark

Prof. Peter Sleight Dept of Cardiovascular Medicine Oxford, UK, comments on the outcome of the TRANSCEND trial - Video

September 04, 2008

TRANSCEND®, parallel trial to ONTARGET®, confirms long-term protective benefits and excellent tolerability profile of telmisartan 80mg on top of current best standard of care